A detailed history of Clal Insurance Enterprises Holdings LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Clal Insurance Enterprises Holdings LTD holds 34,543,812 shares of TEVA stock, worth $774 Million. This represents 5.5% of its overall portfolio holdings.

Number of Shares
34,543,812
Previous 32,339,189 6.82%
Holding current value
$774 Million
Previous $526 Million 18.2%
% of portfolio
5.5%
Previous 5.5%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.81 - $18.96 $34.9 Million - $41.8 Million
2,204,623 Added 6.82%
34,543,812 $621 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $45.3 Million - $61.7 Million
3,544,823 Added 12.31%
32,339,189 $526 Million
Q1 2024

May 09, 2024

SELL
$10.67 - $14.43 $42.8 Million - $57.9 Million
-4,009,765 Reduced 12.22%
28,794,366 $406 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $17.8 Million - $23.3 Million
2,189,462 Added 7.15%
32,804,131 $343 Million
Q3 2023

Nov 06, 2023

SELL
$7.48 - $10.7 $7.48 Million - $10.7 Million
-1,000,000 Reduced 3.16%
30,614,669 $312 Million
Q2 2023

Aug 07, 2023

BUY
$7.2 - $9.47 $92 Million - $121 Million
12,779,003 Added 67.84%
31,614,669 $238 Million
Q1 2023

May 09, 2023

BUY
$8.36 - $11.37 $3.39 Million - $4.62 Million
406,000 Added 2.2%
18,835,666 $161 Million
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $7.77 Million - $9.26 Million
-977,100 Reduced 5.03%
18,429,666 $169 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $3.05 Million - $5.31 Million
444,000 Added 2.34%
19,406,766 $155 Million
Q2 2022

Aug 09, 2022

BUY
$7.38 - $10.4 $10.5 Million - $14.8 Million
1,424,200 Added 8.12%
18,962,766 $138 Million
Q4 2021

Feb 10, 2022

SELL
$7.9 - $10.19 $948,000 - $1.22 Million
-120,000 Reduced 0.68%
17,538,566 $138 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $15.3 Million - $18.6 Million
1,824,764 Added 11.52%
17,658,566 $172 Million
Q2 2021

Aug 11, 2021

BUY
$9.9 - $11.56 $14.1 Million - $16.5 Million
1,428,610 Added 9.92%
15,833,802 $157 Million
Q1 2021

May 12, 2021

SELL
$10.34 - $12.81 $1.76 Million - $2.18 Million
-170,000 Reduced 1.17%
14,405,192 $166 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $5.73 Million - $7.35 Million
665,747 Added 4.79%
14,575,192 $131 Million
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $21.5 Million - $31.8 Million
-2,509,126 Reduced 15.28%
13,909,445 $125 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $25.2 Million - $40.7 Million
3,105,000 Added 23.32%
16,418,571 $202 Million
Q1 2020

Aug 14, 2020

BUY
$6.69 - $13.45 $88.3 Million - $177 Million
13,194,015 Added 11035.85%
13,313,571 $120 Million
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $476,508 - $958,003
71,227 Added 147.38%
119,556 $1.07 Million
Q4 2019

Feb 13, 2020

SELL
$6.53 - $10.72 $16.7 Million - $27.4 Million
-2,553,242 Reduced 98.14%
48,329 $473,000
Q2 2019

Aug 13, 2019

SELL
$8.12 - $15.72 $3.94 Million - $7.64 Million
-485,695 Reduced 15.73%
2,601,571 $24 Million
Q1 2019

May 14, 2019

SELL
$15.58 - $20.01 $10.8 Million - $13.9 Million
-695,030 Reduced 18.38%
3,087,266 $48.4 Million
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $28.7 Million - $46.9 Million
1,968,077 Added 108.48%
3,782,296 $58.3 Million
Q3 2018

Nov 01, 2018

BUY
$21.06 - $25.65 $24 Million - $29.2 Million
1,138,423 Added 168.46%
1,814,219 $39.1 Million
Q2 2018

Aug 08, 2018

BUY
$16.77 - $24.71 $861,374 - $1.27 Million
51,364 Added 8.23%
675,796 $16.4 Million
Q1 2018

May 02, 2018

SELL
$16.68 - $22.07 $15 Million - $19.9 Million
-900,000 Reduced 59.04%
624,432 $10.7 Million
Q4 2017

Feb 13, 2018

SELL
$11.23 - $19.1 $17.5 Million - $29.7 Million
-1,554,248 Reduced 50.48%
1,524,432 $28.9 Million
Q3 2017

Nov 09, 2017

BUY
$15.41 - $32.17 $47.4 Million - $99 Million
3,078,680
3,078,680 $54.2 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.